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 Nearly one in three Americans suffers from cardiovascular disease (CVD), which is 
responsible for over 850,000 U.S. deaths each year. Cardiac rehabilitation (CR) is an effective 
treatment for CVD; CR involves multifaceted interventions of supervised exercise, dietary 
modifications, and counseling. Based on previous research, which is confirmed by this paper’s 
systematic review, CR is effective at improving patients’ functional capacity. Although women 
represent over half of CVD patients, there is surprisingly little known about the comparative 
effectiveness of CR in men and women. This master’s paper seeks to determine whether CR is 
equally effective at improving functional capacity, as determined by maximal metabolic 
equivalents (METs) achieved in men and women. The research is based upon data between 2001 
to 2011 from the University of North Carolina health Care Cardiac Rehabilitation Program at 
Meadowmont. Based on de-identified records from 680 CR participants (189 women; 491 men), 
CR does seem to be somewhat more effective in men than in women. Specifically, adjusting for 
potential confounders, men achieved an average improvement of 2.15 METs after CR and 
women achieved an average improvement of 1.61 METs. It is unclear why men benefit more 
from CR than do women; these results, however, imply that tailoring cardiac rehabilitation 
programs to women may yield further improvement in functional capacity for female 
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 Nearly one in three Americans suffers from cardiovascular disease (CVD), which is 
responsible for over 850,000 American deaths each year.1 
(p 955)
 In fact, fully 35% of American 
deaths each year are due to CVD.2 
(para 1)
 Although cardiovascular disease is often considered a 
disease of men, over half of CVD patients in the U.S. are women, and over half of CVD-related 
deaths in the U.S. occur in women.3 
(p e176)
   
  Cardiac rehabilitation (CR) is an effective CVD treatment.4 CR involves multifaceted 
interventions of supervised exercise, diet modification, and counseling, as well as education on 
the cardiovascular disease process, medications, and returning to a normal life. Cardiac 
rehabilitation has been endorsed by a wide array of medical organizations, including the 
American College of Cardiology Foundation, the American Association of Cardiovascular and 
Pulmonary Rehabilitation, and the American Heart Association.5 Still, according to the Agency 
for Healthcare Research and Quality (AHRQ), fewer than 30% of eligible patients participate in 
CR after a CVD event,6 and AHRQ reports that the rate of CR referral for female patients is 
particularly low.6 
 Despite the general effectiveness of CR and the prevalence of CVD in women, 
surprisingly few studies examine the effectiveness of CR in women. Only five studies have been 
published on the effectiveness of CR in women over the last twenty years. The authors of these 
studies are Cannistra et al., Ades et al., Lavie et al., O’Farrell et al., and Gupta et al. These 
authors show that cardiac rehabilitation does provide benefit to women.7-11 The degree of benefit,  
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however, is largely unclear. Of the five studies above, three did not assess intergroup p values, so 
it is impossible to determine whether differences between men and women are statistically 
significant in these studies.7-9 O’Farrell, Murray, Huston, et al.’s and Gupta, Sanderson, and 
Bittner’s are the only two studies examining intergroup p values; both showed greater 
improvement in post-CR functional capacity for men than for women. However, while Gupta, 
Sanderson, and Bittner found statistically significant differences between men and women, 
O’Farrell, Murray, Huston et al did not.10,11 Given the lack of clarity on this point, our research 
seeks to address the question of whether CR is actually more effective in men than in women. 
 Briefly, our findings suggest that men benefit more from cardiac rehabilitation than do 
women; we will discuss this at greater length in the Results Section of this paper. A secondary 
question is why men benefit more from CR: is the difference a result of innate biological 
differences between the sexes, a consequence of learned, behavioral, and perhaps societal 
differences, or simply a result of cardiac rehabilitation programs that have been preferentially 
designed for male participants? We will review this question at greater length in the Discussion 















Our research uses University of North Carolina (UNC) Health Care System Cardiac 
Rehabilitation Program participant data, from 2001 through 2011. The UNC Program receives 
referrals from unaffiliated private providers as well as from providers within the UNC system. 
Program participants come from five different counties, with the majority (over 56%) of 
participants from Orange County, where the University and Program are located. Approval for 
this research was obtained from the UNC IRB.  
We only included CR participants with both baseline and completion data for the 
outcome of maximal metabolic equivalents (METs) achieved. This yielded exactly 900 
participant records. We excluded 133 records of patients referred to CR for nonischemic 
diagnoses, and we eliminated another 77 records for which independent variable data were 
missing. This yielded a total of 680 participants’ data for analysis.  
Cardiac Rehabilitation Program 
The UNC Health Care Cardiac Rehabilitation Program is an outpatient-based cardiac 
rehabilitation program. In line with CR standards,12 the program includes supervised exercise, 
dietary education, and counseling.13 Cardiac rehabilitation participants are encouraged to attend 
three CR sessions per week for a period of three months, which amounts to thirty-six total 
sessions. This is consistent with the number of total sessions (typically between 24 and 36) in 





 This retrospective observational analysis uses de-identified participant data. The outcome 
measure is absolute change in maximal metabolic equivalents (METs) achieved. This measure is 
assessed at baseline (with the initial measurement taken 1 to 2 weeks before initiation of exercise 
in the cardiac rehabilitation program) and upon Program completion (with the final measurement 
actually taken between 2 and 10 days prior to the end of CR training). METs are expressed in the 
units of mL O2/kg/min.
14 METs achieved “is considered the best measure of cardiovascular 
fitness and exercise capacity,” according to the American Heart Association.15 (p1695)   
The main independent variable is the sex of each participant. Other independent variables 
include age, race, body mass index (BMI), zip code prosperity, total cholesterol at baseline, and 
primary referral diagnosis. “Zip code prosperity” is a proxy measure of respondents’ relative 
affluence; we identified each participant’s residential zip code and then calculated each zip 
code’s average income by dividing the zip code’s total adjusted gross income by its total number 
of returns, based on 2008 IRS data.16 We assessed the relationship of each of these independent 
variables (measured at program initiation) to both the primary independent variable (sex) as well 
as the outcome of interest (absolute change in METs). We ran an analysis of covariance model to 
show the relationship between sex and absolute change in METs, adjusting for all appropriate 
covariates listed above. All statistical analyses were performed using STATA 12.0 Reported p-






Sample Characteristics and Sex-Based Subgroup Analysis 
A total of 680 participants were included. Women were 27.8% of all participants  (189 
women) and men made up the remaining 72.2% (491 men) of the sample (Table 1). Given the 
research question, we closely assessed demographic/baseline differences between male and 
female participants (Table 1). The covariates of race, CR referral indication, and baseline 
cholesterol were significantly different in male and female participants. Fully 15.9% of female 
participants were black while only 5.5% of male participants were black (p< 0.001). Cardiac 
rehabilitation referral indications also showed a significant difference between men and women. 
Medicare and most private insurances will cover CR for just six diagnoses. The covered 
ischemic heart disease (IHD) diagnoses include stable angina, myocardial infarction (MI), 
percutaneous coronary intervention (PCI), and coronary artery bypass grafting (CABG). The two 
covered non-ischemic diagnoses are valve replacement and heart transplant. A higher percentage 
of women (36.5%) compared with men (21.8%) were enrolled in CR because of a previous 
cardiac intervention (either PCI or CABG). In contrast, a higher percentage of men (31.4%) than 
women (19.1%) were enrolled in CR due only to anginal symptoms. It is unclear why this 
difference should exist; the difference itself implies that women in CR may suffer from more 
severe cardiac disease than do men. Women also had higher average cholesterol levels at 
baseline (178 mg/ dL) than did men (160 mg/dL). In our model, we adjusted for all significant 
covariate differences. We found no statistically significant difference by sex for other variables 





                       Demographic & Baseline Health Characteristics  -  by Sex 




Average P Value 
Participants  
by Sex 
   Percent (%) 
    N 
        
 
       27.8 
        189 
 
 
     72.2 






       65.8  
 
     65.1  
 
     65.4  
 
  0.506 
Race 
  Asian (%) 
  Black (%) 
  Hispanic (%) 
  Caucasian (%) 
  Other (%) 
 
 
        2.1 
      15.9                               
        2.1                                 
      79.4                                 
        0.5 
 
 
       1.0 
      5.5                 
      1.6 
     89.2 
       2.7 
 
       1.3 
       8.4 
       1.8 
     86.5 
       2.1 
 
<0.001 








 85,000  
 
  0.127 
 
CR Referral  
Indication 
  Stable Angina (%) 
  *MI (%)    
  **PCI (%) 




      19.1 
      44.4 





     31.4 
     46.8                             
     14.9                        




     27.9 
     46.2 
     16.3 








       29.1 
 
     28.4 
 
     28.5 
 




 prior to CR 
 
       178 
 
      160 
 




* MI = myocardial infarction 
**PCI = percutaneous coronary intervention 
***CABG = coronary artery bypass grafting 
****BMI=body mass index 
 
 





Relationship Between the Outcome of MET Change and the Analyzed Covariates 
The primary research outcome, as discussed previously, is absolute change in METs, the 
AHA standard indicator for CR success.15 This measure was used to evaluate participants’ 
functional capacity. Apart from the main independent variable of sex, several other independent 
variables showed a statistically significant relationship to the outcome variable of MET change. 
CR referral indication and baseline BMI showed statistically significant associations with change 
in METs. Age and race also appeared to be associated with MET change, although these 
associations did not reach statistical significance. Those participants with a history of stable 
angina tended to show the greatest absolute improvement in METs (2.37 mL O2/kg/min increase) 
while those post-CABG tended to show the least (1.79 mL O2/kg/min increase). Participants 
referred for the other two ischemic CR indications (of MI and PCI), meanwhile, showed a degree 
of improvement somewhere in between (Table 2). Those with a higher BMI tended to show less 
improvement in METs compared to those with a lower BMI. Specifically, for every increase of 5 
kg/m
2
 in BMI, participants showed an average 0.23 ml O2/kg/min less improvement in METs. 
Although age and race did not reach statistical significance, younger patients and Caucasians 
(compared to Blacks) did tend to show greater improvement in METs after CR. The small 
numbers of Asians and Hispanics present in the data made it difficult to assess the effect of CR 












Relationship of Demographic/Baseline Variables 
               To Absolute Change in METs 
 
           ABSOLUTE Met Change 
 Beta Value  P Value 
Age 
 
   - 0.010    0.060 
Home Zip Code 
Avg Income  
 0.00314    0.151 
 
BMI 
   





    
   0.0025 
   








  Asian 
  Black 
  Hispanic 
  Caucasian 
 
 
       
       2.08 
       1.73 
       2.98 
       2.02 
 
 
   
0.0877 
CR Referral  
Indication 
  Stable Angina 
 * MI 
  **PCI 
  ***CABG 
 
 
       2.37 
       1.81 
       2.05 
       1.79 
 
 
   0.001 
 
* MI = myocardial infarction 
**PCI = percutaneous coronary intervention 
***CABG = coronary artery bypass grafting 
 




Relationship Between the Outcome of MET Change and Sex 
Men achieved a greater improvement in absolute METs than did women (Table 3). We 
evaluated other variables including age, race, BMI, baseline cholesterol, baseline METs, CR 
indication, and zip code prosperity on the relationship between sex and MET improvement and 
eliminated variables showing no effect at the simple bivariate level. Our final model adjusted 
only for baseline METs and CR indication. The adjusted absolute MET improvement for women 
was 1.59 METs; the improvement for men was 2.16 METs, a 36% difference between men and 
women that is significant at the p < 0.0001 level, even with the relatively smaller number of 

































































  8.63 
 
1.61 
(1.38 to 1.85) 
 
 









    Men 
 
 
8.99 11.14 2.15 
(2.01 to 2.29) 
2.16 
(2.02 to 2.30) 
 
*Adjusted for appropriate Table 1 covariates; CR Referral Dx and Maximal METs Achieved Prior to CR 
 











Our findings support previous research7-9 showing that cardiac rehabilitation enhances 
functional capacity for both men and women. Our research’s important contribution is its 
additional clarification of CR’s differential effects in men and women. The uncertainty of sex 
effects has arisen from the divergent findings of Gupta, Sanderson and Bittner on one hand and 
O’Farell, Murray, Huston, et al. on the other.10,11 Again, Gupta et al. found a statistically 
significant difference between men and women while O’Farell et al. did not. Part of the reason 
for their different findings and conclusions may be the different confounders considered by each 
as well as the different outcomes each group measured. Gupta et al. adjust for participant age, 
race, and baseline functional capacity; O’Farrell et al. do not adjust for any potential 
confounders. Gupta et al. use 6 Minute Walk Test (6 MWT) to assess functional capacity while 
O’Farrell et al. use METs achieved during maximal exertion. As discussed earlier, METs 
achieved is the preferred measure, according to the AHA.15 While Gupta et al’s study more 
effectively adjusts for confounders, O’Farrell et al’s uses the better measure of functional 
capacity. Given these differences between Gupta et al.’s and O’Farrell et al.’s studies, one could 
not conclude that cardiac rehabilitation provided greater benefits to men than to women. We 
found that, after adjusting for confounders and using the preferred measure of METs achieved, 
men still experience a greater improvement in functional capacity following CR than do women 
(Table 3). In addition to being statistically significant, this difference of 0.57 METs or 36% is 
likely to be clinically significant as well.  
Our analysis has several limitations. First, our research was specifically designed to 
assess functional capacity. We used the measure of absolute change in METs achieved (Of note, 
although this measure of absolute change in METs is very common, some other studies have 
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instead reported percent change in METs achieved. It is unclear which measure is more accurate 
for measuring sex differences in functional capacity).7-9 Besides functional capacity, other 
patient-oriented outcomes are quality of life, recurrent cardiac events, and cardiac mortality. All 
of these important outcome measures are beyond the scope of this analysis. 
A second limitation is that we assessed the measure of METs achieved at only two time 
points, program initiation and program completion. Using these time points demonstrates the 
short-term effect of CR; however, extending measurement beyond program completion could 
help demonstrate whether improvement persists. In addition, we limited participants to those 
with MET measurements at both program initiation and completion. Those who failed to 
complete the Program, for example, were excluded from analysis, and it is unclear whether 
excluded patients differed in some ways from included patients. 
 A third limitation is that this analysis uses retrospective observational data from a single 
outpatient-based CR program. Thus, the participant population in this program may not be 
entirely reflective of the cardiac rehabilitation population at large. Also, the specific UNC CR 
Program protocol may differ slightly from those of other CR programs. It is unlikely, however, 
that the UNC Program protocol is significantly different from other programs’ protocols, as the 
American Association of Cardiovascular and Pulmonary Rehabilitation (AACVPR) requires that 
all CR programs use standard guidelines to receive accreditation. 
 Our analysis has several strengths. First, our data set includes 680 program participants; 
this is more than the number of participants in any other similar study. Second, our assessment of 
the relationship between sex and post-CR functional improvement considers a wide array of 
possible confounders. Prior studies have evaluated confounders such as age, race, BMI, and 
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baseline METs. To our knowledge, however, our research is unique in evaluating CR referral 
diagnosis and zip code prosperity; these indicators of cardiovascular disease and socioeconomic 
advantage are important contributors to overall health status. A third strength of our research is 
that it uses the standard measure of “METs achieved ”15 (p1695) to evaluate functional capacity. 
 Our finding that men benefit more from CR than do women do raises the question of 
whether tailoring CR programs to women may result in their greater functional improvement. It 
is not immediately clear, however, how best to tailor CR and its various components (supervised 
exercise, dietary instruction, and counseling) to female participants. One component of CR is 
supervised exercise; researchers have noted that women experience unique barriers to exercise, 
including social stigma against over-exertion and a high prevalence of co-morbidities (such as 
arthritis, osteoporosis, and exercise-induced urinary incontinence) that can complicate engaging 
in exercise programs.17 It is important to take these issues into account when tailoring CR 
exercise programs; as a first step, studies have shown that female-only CR cohorts may be more 
effective than are co-ed groups.18 The second component of CR is dietary modification; research 
has shown that women are better at making heart healthy dietary changes following CR.11 It is 
thus unlikely that tailoring the dietary component of CR to women would yield significant gains, 
although this might be an area in which CR programs could be improved for men. The third 
component of CR is counseling; studies have shown that women typically experience higher 
levels of depression and lower self-efficacy for positive change following a cardiac event.18
,19 
Beckie and Beckstead’s research has shown that tailoring CR counseling to women may prove 
quite effective.18 Thus, based on the results of previous studies by various researchers, modifying 
both the exercise and counseling components of CR appears to hold great promise. Our findings, 
moreover, show a real difference in functional improvement following CR between men and 
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women. Our research thus demonstrates genuine potential for further studies on how to tailor CR 
to better meet female participants’ needs. 
 The first question related to improving CR practice and policy is how to encourage more 
and better research on tailoring CR programs to women; the second question is how to translate 
that research into practice. Consistent with the National Institutes of Health (NIH) Revitalization 
Act of 1993, the NIH has adopted some measures to encourage research on women’s health. 
However, enforcement of the Act has often been inconsistent.20 According to Institute of 
Medicine recommendations, the NIH  needs to be more strict in enforcing rules governing 
women’s health research.20 To spur research in the area, the NIH might even consider offering 
grants specifically dedicated to female-centered CR research. 
 The next challenge is to translate the results of this research into practice. The NIH could 
help bridge this gap between research and practice by providing cardiac rehabilitation programs 
with the results of successful women-centered research studies. The Centers for Medicare and 
Medicaid Services (CMS) and other public and private payers could further encourage the 
implementation of evidence-based women-tailored cardiac rehabilitation programs by offering 
financial incentives to those Centers that adopt and implement these programs. This process of 
encouraging women-tailored research and translating this research to application carries 
considerable challenges. At the same time, given the significant potential benefits,4 the process 







Appendix 1: History of Women’s Health Research 
 
Background 
Historically, women have been under-represented as study participants in clinical trials 
and particularly in cardiovascular research.21 Within cardiovascular disease, the topic of cardiac 
rehabilitation for women has been particularly neglected. The National Institute of Health’s 
(NIH) Office of Research on Women’s Health (ORWH) issued a report in 2010 entitled “A 
Vision for 2020 for Women’s Health Research” which specifically noted the need for “clinical 
practice studies” devoted to “women-centered cardiac rehabilitation.”22 (p291) Similarly, the 
American Heart Association stated in 2005 that “randomized trials are needed to better define the 
role of exercise therapy [such as cardiac rehabilitation] for … specific subgroups of CVD 
patients, particularly females.”23 (para 88)  
The Women’s Movement and Women’s Health Research 
There is a clear need for further attention to certain women’s health topics, and there are 
still significant challenges to achieving sex-based equality in clinical research.20 At the same 
time, the mere fact that prominent organizations such as the AHA and the NIH’s ORWH are 
both focusing on and systematically assessing disparities in women’s health research represents 
real progress; this progress, though still incomplete, is built upon several decades of social, 
political, and policy-level change.  
The Women’s Movement of the 1960s, 70s, and 80s focused on both equality at work 
and home as well as reproductive/medical rights and served to set the stage for the equality 
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movement in women’s health research.24 Bernadine Healy, former director of the NIH, connected 
feminism to this new women’s health movement by calling the new movement to “acknowledge 
that [women are biologically] different from men” the third stage of feminism.25 (p245) Some 
social scientists such as Steven Epstein assert that the women’s health movement is actually 
“post-feminist” because it is a byproduct of “previous feminist struggles.”25 (p245) In either view, 
this movement towards greater attention to women’s health developed in a context created by 
earlier feminist activism and new scholarly and policy analysis. 
Task Force on Women’s Health 
In 1983, as the second wave of the Women’s Movement was waning in many ways, the 
US Assistant Secretary of Health and former Surgeon General, Edward Brandt, created the Task 
Force on Women’s Health Issues “to identify those women’s health issues that are important in 
our society today.”26 (p74)  He explained that he believed the Task Force was necessary largely 
due to the changing roles and responsibilities of American women who are now “involved in a 
spectrum of activities today that were barely discernible on yesterday’s horizon.”26 (p74) The 
circumstances leading up to Brandt’s appointment of the Task Force are beyond the scope of the 
present essay, but it is clear that the Task Force’s Report drew national attention to the issue of 
women’s health. The Task Force Report, moreover, asserted that the lack of women’s health 
research seriously compromised the quality of women’s health care.27 This criticism would lead 







Advisory Committee on Women’s Health Issues &  
Creation of the Office of Research on Women’s Health (ORWH) 
 The first step was the NIH’s creation of the Advisory Committee on Women’s Health 
Issues in 1985 to evaluate implementation of the Task Force’s recommendations. In 1986, the 
Committee attempted to advance women’s health research by strongly encouraging NIH grant 
applicants to include women in their research study populations.28 Unfortunately, the Committee 
had little real authority, and it was unclear whether there was any real improvement in the 
inclusion of women in clinical research. Several groups including the Congressional Caucus for 
Women’s Issues and the Society for Women’s Health Research pressured the government to 
evaluate the inclusion of female subjects in NIH research.25 As a result, the Government 
Accounting Office (GAO) was commissioned to evaluate the situation, and the GAO’s 1990 
Report frankly stated that the “National Institutes of Health has made little progress in 
implementing its policy to encourage the inclusion of women in research study populations.”28 
(p2)
 Reacting to the GAO’s assessment, the NIH created the Office of Research on Women’s 
Health (ORWH) just two months later in September of 1990.29
,30 The Office was expressly 
designed to “ensure that previously articulated NIH policies to support research on women’s 
health issues” were followed and to “ensure that women are appropriately represented in 
biomedical and behavioral research studies supported by NIH.”31 (p2) While the creation of the 
ORWH within the NIH represented a positive development, the ORWH still lacked the explicit 
authority to enforce policies. As such, the ORWH would continue to have real difficulty 





National Institutes of Health Revitalization Act 
 To promote women’s health research and provide the Office of Research on Women’s 
Health with greater authority, Congress crafted and debated various pieces of legislation over the 
next several years. The first proposed piece of legislation was the NIH Revitalization Act of 
1990, which failed to pass the House. The second proposed piece of legislation was the NIH 
Revitalization Act of 1991, which passed the House and Senate only to be stopped at the hand of 
then President George H.W. Bush.25 Finally, in January 1993, Massachusetts Senator Edward 
Kennedy introduced a modified version of the initial Act, called the NIH Revitalization Act of 
1993.25 This new Act both ensured the inclusion of women and minorities in NIH sponsored 
research and reaffirmed the creation of the Office of Research on Women’s Health by the NIH. 
Specifically, the Act provided the ORWH with clear responsibilities and powers to “ensure that 
women are included as subjects in each project of [clinical, NIH funded] research.”32,33 
Interestingly, this part of the Act was not particularly contentious.34 Several other provisions of 
the Act, however, were hotly debated; ultimately, the only significant change to the Act was the 
Nickles Amendment, which prevented HIV positive immigrants from entering the country. 34
,35 
The Revitalization Act of 1993, with only minor modification, successfully passed through 
Congress in May 1993 and would later be signed into law on June 10
th
 1993 by then President 
Bill Clinton.34  
In July of 1993, just a month after the passage of the NIH Revitalization Act, the NIH 
issued guidelines that required grantees to not only include female subjects but also analyze and 
report outcomes by sex. This requirement would help evaluate whether various interventions, 
from surgery to medications to CR, were equally effective in male and female patients. Although 
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issued in 1993, the NIH Revitalization Act and these guidelines only went into effect a year later 
on July 1, 1994.25  
Food and Drug Administration and the Office of Women’s Health 
It is important to note that we, thus far, have focused on the NIH and the NIH’s ORWH; 
in 1994, the Food and Drug Administration (FDA) created its own Office of Women’s Health 
through an agency ruling. The OWH is responsible for funding research on “women’s conditions 
and diseases” and for “encouraging industry to include women in their clinical trials.”36 (para 25) Of 
note, the OWH in 2012 received just $6 million of funding, significantly less than ORWH’s 
$42.3 million. 37 
(para 4)
 In addition, the OWH is only able to encourage the drug industry to 
include women in clinical trials, which are ultimately funded by pharmaceutical companies; the 
ORWH, on the other hand, has a clear statutory mandate to ensure that NIH funded research 
studies adequately address women’s health issues. In theory, therefore, the ORWH has 
significantly greater influence over the direction of NIH research than the OWH has over the 
direction of pharmaceutical research. After the founding of the OWH in 1994, several years 
would pass before the next government ruling on women’s health research. 
2001 Clarifying NIH Guidelines on Women’s Health Research  
In 2001, the NIH issued the “NIH Policy and Guidelines on The Inclusion of Women and 
Minorities as Subjects in Clinical Research.”38 This statement served to clarify the details of what 
constitutes a clinical study and what specific sex-based analysis and reporting are required of 
NIH funded studies.38 In these guidelines, the NIH explicitly stated that research analysis must 
analyze and report the effects of an intervention by sex.38 This 2001 guideline represents the final 
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clarification statement for the NIH Revitalization Act; following its release, there have been no 
official changes or modifications to the national policy on women’s health research. 
Effect of Agencies, Rulings, and Legislation on Women’s Health Research  
 We have discussed the laws, policies, and organizations established to direct women’s 
health research. We turn now to the question of how these changes have affected the actual 
practice of women’s health research. It is important to note, from the beginning, that the answer 
is quite nuanced and complicated. Various groups both within and outside of the government 
have reached differing conclusions about this question. These groups include the Department of 
Health and Human Services (HHS), the General Accounting Office (GAO; known since 2004 as 
the Government Accountability Office), and the Institute of Medicine (IOM). HHS and GAO 
both operate within the federal government; HHS includes the NIH, Center for Disease Control 
(CDC), and many other health-related federal agencies; the GAO is an independent government 
agency that monitors the use of federal moneys. The IOM, on the other hands, is a non-profit 
organization, separate from the government. Interestingly, each of these groups paints a 
somewhat different picture of the current state of women’s health research. Although the 
Department of Health and Human Services (HHS) focuses on the progress made, the Institute of 
Medicine highlights the persistent shortcomings, and the GAO presents a more moderate 
assessment of the state of women’s health research. We will examine each of these reports in 
turn before attempting to draw any conclusions about the actual state of women’s health 
research. 
 The Department of Health and Human Service reported in 2009 that NIH-funded 
extramural research (which represents over 80% of all NIH research) had successfully included a 
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relatively balanced number of male and female participants. The HHS report specifically noted 
that in 2007 and 2008, 46% of participants in NIH funded extramural research were women and 
53% were men.39 
(p44)
 This report, however, did not release the number of studies 
analyzing/reporting their results by sex. Moreover, given that the NIH is a part of HHS, it is 
difficult to determine whether other agendas affected HHS oversight of the report.  
The Institute of Medicine, as an independent non-profit, produced a much more critical 
report in 2010 entitled “Women’s Health Research: Progress, Pitfalls, and Promise.”20 The report 
states that there “has been inadequate enforcement of requirements that representative numbers 
of women be included in clinical trials and that women’s results be reported.”20 (p286) Unlike the 
HHS study which focuses on equal numbers of study participants, the IOM study focuses 
primarily on the reporting of results by sex. The IOM asserts that a “lack of reporting on sex and 
gender differences has hindered identification of potentially important sex differences and 
slowed progress in women’s health research and its translation to clinical practice.”20 (p286) In 
2010, the IOM thus reached very different conclusions from those reached by HHS just one year 
earlier.  
The Government Accounting Office, meanwhile, seems to have found a middle ground. 
Despite its optimistic title, the GAO Report “NIH Has Increased Its Efforts to Include Women in 
Research” reaches a relatively balanced conclusion. While the GAO report was released in 2000, 
it still resonates with both the HHS report of 2009 as well as the IOM report of 2010, and it 
manages to integrate the two in a single coherent assessment of women’s health research. The 
GAO report states that the NIH has achieved a near-equal balance of male and female study 
participants by implementing a new system to evaluate and monitor the number of female study 
participant.40 
(p7)
 The GAO report, however, notes that while the “NIH has made substantial 
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progress in ensuring that women are included in studies … [it has made] less progress in 
encouraging analysis by sex”40 (p7) which is also the primary criticism made by the IOM report. 
Without access to the primary data, it is difficult to assess whether the HHS, IOM, or the 
GAO report most accurately reflects the current state of women’s health research. Drawing upon 
the collective insights from these reports, however, we see that while there may be more female 
subjects in NIH funded research, it appears that few studies analyze and report results by sex. 
This is definitely the case for the discipline of cardiac rehabilitation, which serves as the focus of 
this paper. While cardiac rehabilitation has been available to patients for over thirty years, only 
five studies have evaluated the effectiveness of CR in men and women. There is a great need for 
more sex-based cardiac rehabilitation research. Studies evaluating the relative benefits of CR 
components for each sex and studies assessing the relative effectiveness of tailored CR 











Appendix 2: Systematic Review of Cardiac Rehabilitation 
 
Background 
Cardiac rehabilitation (CR) is a multifaceted program designed to assist patient recovery 
from various forms of heart disease. The history of cardiac rehabilitation involves a gradual 
paradigm shift that occurred over several decades. In the early 20
th
 century, prevailing medical 
wisdom dictated that physicians place their patients on complete bed rest for at least six weeks 
following a heart attack.41 
(p1793)
 By the 1950s, however, this dogma was increasingly brought 
into question by Levine, Lown, and others.41 By the 1960s, Hellerstein had developed a 
comprehensive activity program for heart attack patients. Moreover, in 1968, he published his 
pivotal work, “Exercise Therapy in Coronary Disease,” which still acts as the foundation for 
modern cardiac rehabilitation.41 
(p1795)
    
Modern cardiac rehabilitation involves several key components: a supervised/tailored 
exercise program, nutritional/dietary counseling, and emotional/motivational support 42,42. In the 
words of the American Heart Association, the goal of cardiac rehabilitation is to help patients 
“increase physical fitness, reduce cardiac symptoms, improve health and reduce the risk of future 
heart problems.”42 (para 4) CR is supported by a wide array of medical organizations including the 
American College of Cardiology Foundation, the American Association of Cardiovascular and 
Pulmonary Rehabilitation, and the American Heart Association.43 This systematic review 
examines whether this broad support for cardiac rehabilitation is grounded in current research. 
We specifically seek to answer the question: how effective is cardiac rehabilitation at improving 
functional capacity in heart attack (myocardial infarction/MI) patients? The results of this review 
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will help inform and provide background for my master’s paper as whole, which examines the 




Types of Studies 
 We restricted our review to randomized controlled trials (RCTs) comparing patients 
randomized to receive either standard treatment
2
, ie control, or cardiac rehabilitation in addition 
to standard treatment, ie intervention. We chose not to include observational studies because of 
the difficulty in determining whether potential differences in outcome in such studies are the 
result of CR itself or the result of baseline intervention/control differences. This issue of baseline 
differences is especially concerning because previous studies have documented significant 




 Diagnoses qualifying patients for cardiac rehabilitation (CR) are extremely diverse. 
Medicare and most private insurance companies will cover CR for a variety of indications 
including MI within the last 12 months, coronary artery bypass surgery, angina pectoris, heart 
                                                          
1
 It is important to note that while this systematic review specifically examines CR for heart attack patients, the 
original research in this paper evaluates CR for a broad range of ischemic heart disease (IHD) conditions including 
heart attack, angina, CABG, and PCI. Also, while the systematic review examines men and women together, our 
research evaluates these groups separately. These differences are intentional, with the systematic review 
assessing whether there appears to be any benefit to CR while our research attempts to measure the degree of 
benefit in various groups (men compared to women, heart attack patients compared to angina patients, etc).    
2
 For the purposes of this systematic review, standard treatment does not include cardiac rehabilitation or any of 
the components of CR.  
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valve repair/replacement, angioplasty or coronary stenting, and heart or heart/lung transplant. 
These CR diagnoses are each quite distinct and involve very different disease processes; 
consequently, it is not clear that cardiac rehabilitation is equally effective in addressing each 
condition. We have thus specifically chosen to limit the review to studies of heart attack patients, 
as heart attack is one of the most common qualifying conditions for CR.46  
 
Intervention 
 We required that included studies specifically and explicitly assess the effectiveness of 
cardiac rehabilitation. The core components of cardiac rehabilitation are patient assessment, 
exercise training, physical activity counseling, nutritional counseling, and psychosocial 
management.47 We excluded any study that did not include all of these core CR components as 
part of the intervention. 
 
Control 
 We limited studies to those in which control participants received only standard care. 
Any studies offering control participants more than standard care 
ii
 were excluded. As part of 
standard care, all participants in the included studies were instructed to continue to follow-up 







  We restricted studies to those evaluating the outcome of exercise capacity. Exercise 
capacity was chosen both because it is an important patient-oriented outcome and because our 
research is, similarly, aimed at addressing the effect of CR on exercise capacity. Two different 
indices of exercise capacity were used by the included studies:  peak VO2 and total work 
capacity. Peak VO2 is the volume of oxygen consumed per min per kg by an individual at 
maximal exertion. Total work capacity (TWC) is the amount of work that an individual can 
undertake without becoming symptomatic; TWC is measured in kg per meter.  
In terms of the timeframe for measuring outcomes, we only required that studies measure 
outcomes at baseline (before CR) and upon completion of CR. Some included studies 
additionally measured outcomes at time points several months to years after participants’ 
completion of CR. 
 
Search Methods for Study Identification 
 On February 24, 2012, we searched the MEDLINE database using the MESH term 
“myocardial infarction” and the keyword “cardiac rehabilitation” 3. We limited the search results 
to English language papers published within the last ten years (2003 to 2012). We retrieved a 
total of 368 articles. After we used the previously elaborated criteria to screen the abstracts of 
these articles, only nineteen articles remained. We then closely reviewed the eligibility of these 
nineteen articles and were left with only three articles. To be thorough, we also conducted a hand 
search of two of the most recent systematic reviews on the topic, which were published in the 
                                                          
3
 Unfortunately, cardiac rehabilitation is not a MESH term in MEDLINE.  
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American Heart Journal and Cochrane.  From this hand search, only three articles were obtained, 
and we had previously found each of these three articles using MEDLINE. Thus, despite 
assessing 368 articles for inclusion, our review includes only three studies because of stringent 
eligibility criteria.  
 
Results 
 The three included studies are Lee, Chen, Hsu, et al.’s “The Effect of Cardiac 
Rehabilitation on Myocardial Perfusion Reserve in Postinfarction Patients”, Marchionni, 
Fattirolli, Fumagelli, et al.’s “Improved Exercise Tolerance and Quality of Life with Cardiac 
Rehabilitation of Older Patients after Myocardial Infarction” and Giallauria, De Lorenzo, Pilerci, 
et al.’s “Favorable Effects of Exercise Training on N-terminal Pro-Brain Natriuretic Peptide 
(pro-BNP) Plasma Levels in Elderly Patients after Acute Myocardial Infarction.”43,48-50  (Of note, 
in addition to examining exercise capacity, some of the studies also looked at other outcomes 
such as myocardial perfusion or pro-BNP levels.) Both Lee et al.’s study and Gialluria et al.’s 
study measure peak VO2 to assess exercise capacity48,50 while Marchionni et al.’s study relied on 
bicycle ergometry testing to assess total work capacity.49 
 In all three studies, cardiac rehabilitation patients showed improvement in exercise 
capacity (measured either by peak VO2 or by TWC) following the intervention.48-50 In contrast, 
control patients showed essentially no change in exercise capacity at the end of the study.48-50 





 Peak VO2 is a commonly used measure of exercise capacity. Lee, Chen, Hsu, et al. report 
that study participants’ peak VO2 increased after CR from an average of 22.2 mL/kg/min to an 
average of 25.0 mL/kg/min. This represents an increase of 2.8 mL/kg/min or 12.6%; the peak 
VO2 for Lee et al.’s control group, on the other hand, decreased by 0.3 mL/kg/min or 1.3%. The 
associated intra-group p value for CR patients in this study is less than 0.01; unfortunately, no 
inter-group p value is reported. 48 
(p1398-1399)
 Giallauria, De Lorenzo, Pilerci, et al. likewise report 
that CR is associated with a marked improvement in peak VO2. Participants’ average peak VO2 
improved from 16.3 mL/kg/min to 20.5 mL/kg/min after CR; this represents a change of 3.8 
mL/kg/min or 23.3% which is significantly different (inter-group p value of 0.007) from the 




TWC (Total Work Capacity) 
Marchionni, Fattirolli, Fumagelli, et al.’s study is the only included study that does not 
examine peak VO2. This study instead assesses total work capacity. It is difficult to evaluate the 
effect of CR in this study for three reasons. First, the study only evaluates the effect of CR for 
age-stratified groups (breaking the sample down into those 45 to 65 years old, those 65 to 75 
years old, and those over 75 years old) and does not assess the overall effect of CR on the entire 
sample.49 
(p2205)
 Second, the study does not report specific values for Total Work Capacity, either 
before or after CR.49 
(p2205)
 And third, the study reports intra-group p values but not inter-group p 
values.49 
(p2205)
 Still, TWC improved in each of the age-stratified CR groups, with intra-group p 
value less than 0.001 for each age-stratified group. TWC for controls also tended to improve; 
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however, this improvement did not achieve statistical significance, based on intra-group p 
values.49 
(p2205)
 Although it would admittedly be helpful to have more information, CR does seem 
to benefit TWC, based on the results of this study.  
 
Discussion 
 We’ve reviewed the results of the three RCTs assessing the effect of cardiac 
rehabilitation on various functional measures. The specific measures discussed include peak 
VO2 and Total Work Capacity (TWC). We will first discuss the measure of peak VO2 and then 
move on to discuss the measure of TWC. 
Both of the studies which assess peak VO2 favor cardiac rehabilitation. Moreover, both 
Lee et al. and Giallauria et al. report a statistically significant increase in peak VO2 in the CR 
group compared to the control group.48,50 The specific percent improvement in peak VO2 does 





 For various reasons, it is difficult to compare the 
percent improvement in peak VO2 across studies. First, the patient populations in these two 










third, the sample size for both studies is quite small, with only 39 total participants in Lee et al.’s 
study and 44 total participants in Giallauria et al.’s study.48 (p1395), 50 (p625) For all of these reasons, 
it is not surprising that the percent improvement in peak VO2 is somewhat different between 
these two studies.  Still, it is important to note that both studies show marked improvements in 
peak VO2 following CR. 
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 The other functional outcome reported was TWC, assessed by Marchionni, Fattirolli, 
Fumagelli, et al. It is, however, difficult to discuss this measure at length because no specific 
TWC values are provided and only age-stratified results are available. Still, although Marchionni 
et al. are assessing a different functional outcome from Lee et al. and Giallauria et al, this study 
also shows marked functional improvement after cardiac rehabilitation.49 
(p2205)
 
 In conclusion, each of these randomized controlled trials shows a strong association 
between cardiac rehabilitation and functional improvement, measured by either peak VO2 or 
TWC. Cardiac rehabilitation thus seems to be beneficial, by and large, for patients who have 
suffered a heart attack. The question remains of whether cardiac rehabilitation is equally 
beneficial for men and women. And although no RCTs have been designed to address this 
question, we are hopeful that our observational research, in the context of previous observational 
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